Telmisartan and losartan: The marked differences between their chemical and pharmacological properties may explain the difference in therapeutic efficacy in hospitalized patients with COVID-19.
Pharmacol Res Perspect
; 11(2): e01083, 2023 04.
Article
in English
| MEDLINE | ID: covidwho-2302766
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Hypertension
Limits:
Humans
Language:
English
Journal:
Pharmacol Res Perspect
Year:
2023
Document Type:
Article
Affiliation country:
Prp2.1083
Similar
MEDLINE
...
LILACS
LIS